Table 3.
Serum levels of GHRH in tumor-free nude mice and nude mice bearing xenografts of H-69 SCLC treated with GHRH antagonist JV-1-36 at doses of 20 μg/day or 10 μg/day per animal
Mice | GHRH, ng/ml |
---|---|
Tumor-free | 4.75 ± 0.63 |
H-69-bearing | |
Control | 9.2 ± 1.45 |
JV-1-36 (10 μg/day) | 10.63 ± 1.05 |
JV-1-36 (20 μg/day) | 5.49 ± 0.61 |